(Q45402887)

14 December 2017

title

Anti-hepatitis C virus activity of albinterferon alfa-2b in cell culture (English)

1 reference

14 December 2017

1 reference

Chen Liu

1

1 reference

14 December 2017

Haizhen Zhu

2

1 reference

14 December 2017

G Mani Subramanian

3

1 reference

14 December 2017

Paul A Moore

4

1 reference

14 December 2017

Yiling Xu

5

1 reference

14 December 2017

David R Nelson

6

1 reference

14 December 2017

publication date

15 June 2007

1 reference

14 December 2017

1 reference

14 December 2017

volume

37

1 reference

14 December 2017

issue

11

1 reference

14 December 2017

page(s)

941-947

1 reference

Global epidemiology of hepatitis C virus infection

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Projecting future complications of chronic hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Efficient initiation of HCV RNA replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Effect of alpha interferon on the hepatitis C virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00142.X

10.1111/J.1872-034X.2007.00142.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference